Combination Therapy for Pancreatic Cancer
Phase 2
60
about 3 years
18+
5 sites in NC, NY, PA +1
Why this study is shown
What this study is about
This trial is testing a combination of drugs, radiation therapy, and immunotherapy to treat localized pancreatic cancer. The goal is to see if this treatment approach can safely boost the immune system's ability to fight the tumor.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Stereotactic body radiotherapy (SBRT)
- 2.Take Etrumadenant
- 3.Take Modified FOLFIRINOX
- +2 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
chemotherapy
infusion
Secondary: Count of Grade 3 or Higher Adverse Events, Overall Survival, Pathologic Complete Response Rate, Recurrence free survival